Lung transplantation

F1000Prime Reports

Volumn 5, Issue , 2013, Pages

  Meyer, Keith C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17;

ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HEART DEATH; HLA MATCHING; HUMAN; INFECTION PREVENTION; LUNG ALLOCATION SCORING SYSTEM; LUNG PERFUSION; LUNG TRANSPLANTATION; ORGAN DONOR; OXYGENATION; SCORING SYSTEM; TISSUE ENGINEERING; TREATMENT OUTCOME; XENOTRANSPLANTATION;

EID: 84878271110     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P5-16     Document Type: Article

References (135)

1. Kotloff RM, Thabut G: Lung transplantation. Am J Respir Crit Care Med 2011, 184:159-71.
2. Spahr J, Meyer K: Lung transplantation. In Primer on Transplantation. (3rd Edition). Edited by Hricik D, American Society of Transplantation. Oxford, UK: Wiley-Blackwell; 2011:205-37.
3. Eberlein M, Garrity ER, Orens JB: Lung allocation in the United States. Clin Chest Med 2011, 32:213-22.
4. Yusen RD, Shearon TH, Qian Y, Kotloff R, Barr ML, Sweet S, Dyke DB, Murray S: Lung transplantation in the United States, 1999-2008. Am J Transplant 2010, 10:1047-68.
5. Russo MJ, Iribarne A, Hong KN, Davies RR, Xydas S, Takayama H, Ibrahimiye A, Gelijns AC, Bacchetta MD, D'Ovidio F, Arcasoy S, Sonett JR: High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest 2010, 137:651-7.
6. Merlo CA, Weiss ES, Orens JB, Borja MC, Diener-West M, Conte JV, Shah AS: Impact of U.S. Lung Allocation Score on survival after lung transplantation. J Heart Lung Transplant 2009, 28:769-75.
7. Horai T, Shigemura N, Gries C, Pilewski J, Bhama JK, Bermudez CA, Zaldonis D, Toyoda Y: Lung transplantation for patients with high lung allocation score: single-center experience. Ann Thorac Surg 2012, 93:1592-7; discussion 1597.
8. Russo MJ, Worku B, Iribarne A, Hong KN, Yang JA, Vigneswaran W, Sonett JR: Does lung allocation score maximize survival benefit from lung transplantation? J Thorac Cardiovasc Surg 2011, 141:1270-7.
9. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS: Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann Thorac Surg 2009, 88:1757-64.
10. George TJ, Beaty CA, Kilic A, Shah PD, Merlo CA, Shah AS: Outcomes and temporal trends among high-risk patients after lung transplantation in the United States. J Heart Lung Transplant 2012, 31:1182-91.
11. Kilic A, Merlo CA, Conte JV, Shah AS: Lung transplantation in patients 70 years old or older: have outcomes changed after implementation of the lung allocation score? J Thorac Cardiovasc Surg 2012, 144:1133-8.
12. Russo MJ, Davies RR, Hong KN, Iribarne A, Kawut S, Bacchetta M, D'Ovidio F, Arcasoy S, Sonett JR: Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg 2009, 138:1234-1238.e1.
13. Gries CJ, Rue TC, Heagerty PJ, Edelman JD, Mulligan MS, Goss CH: Development of a predictivemodel for long-term-survival after lung transplantation and implications for the lung allocation score. J Heart Lung Transplant 2010, 29:731-8.
14. Hook JL, Lederer DJ: Selecting lung transplant candidates: where do current guidelines fall short? Expert Rev RespirMed 2012, 6:51-61.
15. Murphey CL, Forsthuber TG: Trends in HLA antibody screening and identification and their role in transplantation. Expert Rev Clin Immunol 2008, 4:391-9. (Pubitemid 351907757)
16. Tait BD, Hudson F, Cantwell L, Brewin G, Holdsworth R, Bennett G, Jose M: Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology (Carlton) 2009, 14:247-54.
17. Zangwill SD, Ellis TM, Zlotocha J, Jaquiss RD, Tweddell JS, Mussatto KA, Berger S: The virtual crossmatch-a screening tool for sensitized pediatric heart transplant recipients. Pediatr Transplant 2006, 10:38-41.
18. Tambur AR, Ramon DS, Kaufman DB, Friedewald J, Luo X, Ho B, Skaro A, Caicedo J, Ladner D, Baker T, Fryer J, Gallon L, Miller J, Abecassis MM, Leventhal J: Perception versus reality?: Virtual crossmatch-how to overcome some of the technical and logistic limitations. Am J Transplant 2009, 9:1886-93.
19. Cecka JM, Kucheryavaya AY, Reinsmoen NL, Leffell MS: Calculated PRA: initial results show benefits for sensitized patients and a reduction inpositive crossmatches. Am J Transplant 2011, 11:719-24.
20. El-Awar N, Lee J, Terasaki PI: HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005, 66:989-97. (Pubitemid 41790535)
21. Mason DP, Thuita L, Alster JM, Murthy SC, Budev MM, Mehta AC, Pettersson GB, Blackstone EH: Should lung transplantation be performed using donation after cardiac death? The United States experience. J Thorac Cardiovasc Surg 2008, 136:1061-6.
22. de Oliveira NC, Osaki S, Maloney JD, Meyer KC, Kohmoto T, D'Alessandro AM, Love RB: Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010, 139:1306-15.
23. Wierup P, Haraldsson A, Nilsson F, Pierre L, Scherstén H, Silverborn M, Sjöberg T, Westfeldt U, Steen S: Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 2006, 81:460-6. (Pubitemid 43120535)
24. Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, Anraku M, Sato M, Harwood S, Pierre A, Waddell TK, de Perrot M, Liu M, Keshavjee S: Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008, 27:1319-25.
25. Cypel M, Rubacha M, Yeung J, Hirayama S, Torbicki K, Madonik M, Fischer S, Hwang D, Pierre A, Waddell TK, de Perrot M, Liu M, Keshavjee S: Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009, 9:2262-9.
26. Ingemansson R, Eyjolfsson A, Mared L, Pierre L, Algotsson L, Ekmehag B, Gustafsson R, Johnsson P, Koul B, Lindstedt S, Lührs C, Sjöberg T, Steen S: Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg 2009, 87:255-60.
27. Yeung JC, Cypel M, Waddell TK, van Raemdonck D, Keshavjee S: Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques-non-heart-beating donor lung retrieval and ex vivo donor lung perfusion. Thorac Surg Clin 2009, 19:261-74.
28. Cypel M, Yeung JC, Keshavjee S: Novel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning. Clin Chest Med 2011, 32:233-44.
29. Cypel M, Keshavjee S: Extracorporeal lung perfusion. Curr Opin Organ Transplant 2011, 16:469-75.
30. Zych B, Popov AF, Stavri G, Bashford A, Bahrami T, Amrani M, de Robertis F, Carby M, Marczin N, Simon AR, Redmond KC: Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 2012, 31:274-81.
31. Sadaria MR, Smith PD, Fullerton DA, Justison GA, Lee JH, Puskas F, Grover FL, Cleveland JC, Reece TB, Weyant MJ: Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion. Ann Thorac Surg 2011, 92:478-84.
32. Aigner C, Slama A, Hötzenecker K, Scheed A, Urbanek B, Schmid W, Nierscher FJ, Lang G, Klepetko W: Clinical ex vivo lung perfusion-pushing the limits. Am J Transplant 2012, 12:1839-47.
33. Cypel M, Liu M, Rubacha M, Yeung JC, Hirayama S, Anraku M, Sato M, Medin J, Davidson BL, de Perrot M, Waddell TK, Slutsky AS, Keshavjee S: Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med 2009, 1:4ra9.
34. Yeung JC, Wagnetz D, Cypel M, Rubacha M, Koike T, Chun Y, Hu J, Waddell TK, Hwang DM, Liu M, Keshavjee S: Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig. Mol Ther 2012, 20:1204-11.
35. Cypel M, Keshavjee S: The clinical potential of ex vivo lung perfusion. Expert Rev Respir Med 2012, 6:27-35.
36. Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH: Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg 2010, 139:765-773.e1.
37. Gottlieb J, Warnecke G, Hadem J, Dierich M, Wiesner O, Fühner T, Strueber M, Haverich A, Welte T: Outcome of critically ill lung transplant candidates on invasive respiratory support. Intensive Care Med 2012, 38:968-75.
38. Bittner HB, Lehmann S, Rastan A, Garbade J, Binner C, Mohr FW, Barten MJ: Outcome of extracorporeal membrane oxygenation as a bridge to lung transplantation and graft recovery. Ann Thorac Surg 2012, 94:942-9; author reply 949-50.
39. Lang G, Taghavi S, Aigner C, Rényi-Vámos F, Jaksch P, Augustin V, Nagayama K, Ghanim B, Klepetko W: Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation 2012, 93:729-36.
40. Javidfar J, Bacchetta M: Bridge to lung transplantation with extracorporeal membrane oxygenation support. Curr Opin Organ Transplant 2012, 17:496-502.
41. Nosotti M, Rosso L, Tosi D, Palleschi A, Mendogni P, Nataloni IF, Crotti S, Tarsia P: Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation. Interact Cardiovasc Thorac Surg 2013, 16:55-9.
42. Ius F, Kuehn C, Tudorache I, Sommer W, Avsar M, Boethig D, Fuehner T, Gottlieb J, Hoeper M, Haverich A, Warnecke G: Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg 2012, 144:1510-6.
43. Shafii AE, Mason DP, Brown CR, Vakil N, Johnston DR, McCurry KR, Pettersson GB, Murthy SC:Growing experience with extracorporealmembrane oxygenation as a bridge to lung transplantation. ASAIO J 2012, 58:526-9.
44. Javidfar J, Brodie D, Iribarne A, Jurado J, LavelleM, Brenner K, Arcasoy S, Sonett J, Bacchetta M: Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery. J Thorac Cardiovasc Surg 2012, 144:716-21.
45. Garcia JP, Iacono A, Kon ZN, Griffith BP: Ambulatory extracorporeal membrane oxygenation: a new approach for bridge-to-lung transplantation. J Thorac Cardiovasc Surg 2010, 139:e137-9.
46. Shafii AE, McCurry KR: Subclavian insertion of the bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation. Ann Thorac Surg 2012, 94:663-5.
47. Mangi AA, Mason DP, Yun JJ, Murthy SC, Pettersson GB: Bridge to lung transplantation using short-term ambulatory extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2010, 140:713-5.
48. Lowman JD, Kirk TK, Clark DE: Physical therapy management of a patient on portable extracorporeal membrane oxygenation as a bridge to lung transplantation: a case report. Cardiopulm Phys Ther J 2012, 23:30-5.
49. Garcia JP, Kon ZN, Evans C, Wu Z, Iacono AT, McCormick B, Griffith BP: Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls. J Thorac Cardiovasc Surg 2011, 142:755-61.
50. 2 removal devices in patients awaiting lung transplantation: an initial experience. Transplant Proc 2010, 42:1255-8.
51. Camboni D, Philipp A, Hirt S, Schmid C: Possibilities and limitations of a miniaturized long-term extracorporeal life support system as bridge to transplantation in a case with biventricular heart failure. Interact Cardiovasc Thorac Surg 2009, 8:168-70.
52. Taylor K, Holtby H: Emergency interventional lung assist for pulmonary hypertension. Anesth Analg 2009, 109:382-5.
53. Camboni D, Philipp A, Haneya A, Puehler T, Arlt M, Hilker M, Schmid FX, Schmid C: Serial use of an interventional lung assist device and a ventricular assist device. ASAIO J 2010, 56:270-2.
54. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A: International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010, 89:779-95.
55. Hodson EM, Craig JC, Strippoli GFM, Webster AC: Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2008: CD003774.
56. Palmer SM, Limaye AP, Banks M, Gallup D, Chapman J, Lawrence EC, Dunitz J, Milstone A, Reynolds J, Yung GL, Chan KM, Aris R, Garrity E, Valentine V, McCall J, Chow S, Davis RD, Avery R: Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med 2010, 152:761-9.
57. Verleden GM, Vos R, de Vleeschauwer SI, Willems-Widyastuti A, Verleden SE, Dupont LJ, van Raemdonck DEM, Vanaudenaerde BM: Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transpl Int 2009, 22:771-9.
58. Todd JL, Palmer SM: Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest 2011, 140:502-8.
59. Meyer KC: Bronchiolitis obliterans syndrome. Curr Respir Care Rep 2012, 1:147-56.
60. Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, Keshavjee S: Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011, 30:735-42.
61. Verleden GM, Vos R, Verleden SE, de Wever W, de Vleeschauwer SI, Willems-Widyastuti A, Scheers H, Dupont LJ, van Raemdonck DE, Vanaudenaerde BM: Survival determinants in lung transplant patients with chronic allograft dysfunction. Transplantation 2011, 92:703-8.
62. Woodrow JP, Shlobin OA, Barnett SD, Burton N, Nathan SD: Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation. J Heart Lung Transplant 2010, 29:1159-64.
63. Vos R, Vanaudenaerde BM,Ottevaere A, Verleden SE, de Vleeschauwer SI, Willems-Widyastuti A, Wauters S, van Raemdonck DE, Nawrot TS, Dupont LJ, Verleden GM: Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? J Heart Lung Transplant 2010, 29:1358-68.
64. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S: Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002, 21:297-310. (Pubitemid 34224094)
65. Vos R, Vanaudenaerde BM, Verleden SE, de Vleeschauwer SI, Willems-Widyastuti A, van Raemdonck DE, Schoonis A, Nawrot TS, Dupont LJ, Verleden GM: A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 2011, 37:164-72.
66. Yates B, Murphy DM, Forrest IA, Ward C, Rutherford RM, Fisher AJ, Lordan JL, Dark JH, Corris PA: Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005, 172:772-5. (Pubitemid 41324235)
67. Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, Seiler DA, Dauber JH, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, Burckart GJ, McCurry KR, Griffith BP: A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med 2006, 354:141-50. (Pubitemid 43076711)
68. Gasper WJ, Sweet MP, Hoopes C, Leard LE, Kleinhenz ME, Hays SR, Golden JA, Patti MG: Antireflux surgery for patients with endstage lung disease before and after lung transplantation. Surg Endosc 2008, 22:495-500. (Pubitemid 351238241)
69. Hoppo T, Jarido V, Pennathur A, Morrell M, Crespo M, Shigemura N, Bermudez C, Hunter JG, Toyoda Y, Pilewski J, Luketich JD, Jobe BA: Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg 2011, 146:1041-7.
70. Cantu E, Appel JZ, Hartwig MG, Woreta H, Green C, Messier R, Palmer SM, Davis RD: J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004, 78:1142-51; discussion 1142-51. (Pubitemid 39303826)
71. Davis RD, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, Palmer SM: Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003, 125:533-42. (Pubitemid 36373899)
72. Mertens V, Blondeau K, Pauwels A, Farre R, Vanaudenaerde B, Vos R, Verleden G, van Raemdonck DE, Dupont LJ, Sifrim D: Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig Dis Sci 2009, 54:972-9.
73. Mertens V, Blondeau K, van Oudenhove L, Vanaudenaerde B, Vos R, Farre R, Pauwels A, Verleden G, van Raemdonck D, Sifrim D, Dupont LJ: Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin. Am J Transplant 2011, 11:329-35.
74. Bobadilla JL, Jankowska-Gan E, Xu Q, Haynes LD, Munoz del Rio A, Meyer K, Greenspan DS, de Oliveira N, Burlingham WJ, Maloney JD: Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome. Chest 2010, 138:363-70.
75. Jaksch P, Scheed A, Keplinger M, Ernst M, Dani T, Just U, Nahavandi H, Klepetko W, Knobler R: A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012, 31:950-7.
76. Marques MB, Schwartz J: Update on extracorporeal photopheresis in heart and lung transplantation. J Clin Apher 2011, 26:146-51.
77. Hachem RR, Yusen RD, Meyers BF, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP: Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant 2010, 29:973-80.
78. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, Wilkes DS: IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007, 117:3498-506. (Pubitemid 350097005)
79. Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, Braun RK, Hayney MS, Munoz del Rio A, Meyer K, Greenspan DS, Torrealba J, Heidler KM, Cummings OW, Iwata T, Brand D, Presson R, Burlingham WJ, Wilkes DS: Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008, 177:660-8. (Pubitemid 351442174)
80. Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M, Steward N, Aloush A, Hachem R, Trulock E, Meyers B, Patterson GA, Mohanakumar T: Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant 2011, 30:624-31.
81. Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T: Antibodies to K-a 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant 2012, 12:2164-71.
82. Takenaka M, Subramanian V, Tiriveedhi V, Phelan D, Hachem R, Trulock E, Gelman AE, Patterson GA, Hoshinaga K, Mohanakumar T: Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection. J Heart Lung Transplant 2012, 31:1214-22.
83. Yasufuku K, Heidler KM, O'Donnell PW, Smith GN, Cummings OW, Foresman BH, Fujisawa T, Wilkes DS: Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 2001, 25:26-34. (Pubitemid 32682702)
84. Yasufuku K, Heidler KM, Woods KA, Smith GN, Cummings OW, Fujisawa T, Wilkes DS: Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002, 73:500-5. (Pubitemid 34193606)
85. Mizobuchi T, Yasufuku K, Zheng Y, Haque MA, Heidler KM, Woods K, Smith GN, Cummings OW, Fujisawa T, Blum JS, Wilkes DS: Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 2003, 171:1140-7. (Pubitemid 36900041)
86. Yamada Y, Sekine Y, Yoshida S, Yasufuku K, Petrache I, Benson HL, Brand DD, Yoshino I, Wilkes DS: Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 2009, 183:237-45.
87. Vanaudenaerde BM, de Vleeschauwer SI, Vos R, Meyts I, Bullens DM, Reynders V, Wuyts WA, van Raemdonck DE, Dupont LJ, Verleden GM: The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008, 8:1911-20.
88. Afzali B, Lombardi G, Lechler RI, Lord GM: The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46. (Pubitemid 46365005)
89. Tiriveedhi V, Takenaka M, Ramachandran S, Gelman AE, Subramanian V, Patterson GA, Mohanakumar T: T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease. Am J Transplant 2012, 12:2663-74.
90. Fukami N, Ramachandran S, Takenaka M, Weber J, Subramanian V, Mohanakumar T: An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules. Am J Transplant 2012, 12:867-76.
91. Serody JS, Hill GR: The IL-17 differentiation pathway and its role in transplant outcome. Biol Blood Marrow Transplant 2012, 18: S56-61.
92. Shilling RA, Wilkes DS: Role of Th17 cells and IL-17 in lung transplant rejection. Semin Immunopathol 2011, 33:129-34.
93. Krebs R, Tikkanen JM, Ropponen JO, JeltschM, Jokinen JJ, Ylä-Herttuala S, Nykänen AI, Lemström KB: Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Am J Pathol 2012, 181:1607-20.
94. Tesar BM, Du W, Shirali AC, WalkerWE, ShenH,Goldstein DR: Aging augments IL-17 T-cell alloimmune responses. Am J Transplant 2009, 9:54-63.
95. Vanaudenaerde BM, Dupont LJ, Wuyts WA, Verbeken EK, Meyts I, Bullens DM, Dilissen E, Luyts L, van Raemdonck DE, Verleden GM: The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006, 27:779-87. (Pubitemid 44914203)
96. Vanaudenaerde BM, Wuyts WA, Dupont LJ, van Raemdonck DE, Demedts MM, Verleden GM: Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003, 22:1280-3. (Pubitemid 37324703)
97. Vanaudenaerde BM, Verleden SE, Vos R, de Vleeschauwer SI, Willems-Widyastuti A, Geenens R, van Raemdonck DE, Dupont LJ, Verbeken EK, Meyts I: Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am J Respir Crit Care Med 2011, 183:977-86.
98. Shi Q, Cao H, Liu J, Zhou X, Lan Q, Zheng S, Liu Z, Li Q, Fan H: CD4+Foxp3+ regulatory T cells induced by TGF-b, IL-2 and all-trans retinoic acid attenuate obliterative bronchiolitis in rat trachea transplantation. Int Immunopharmacol 2011, 11:1887-94.
99. NeujahrDC, Larsen CP: Regulatory T cells in lung transplantation-an emerging concept. Semin Immunopathol 2011, 33:117-27.
100. Braun RK, Molitor-Dart M, Wigfield C, Xiang Z, Fain SB, Jankowska-Gan E, Seroogy CM, Burlingham WJ, Wilkes DS, Brand DD, Torrealba J, Love RB: Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection. Transplantation 2009, 88:1341-8.
101. Jaffar Z, Ferrini ME, Girtsman TA, Roberts K: Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 2009, 39:3307-14.
102. Griffin DO, Rothstein TL: Human "orchestrator" CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity. Mol Med 2012, 18:1003-8.
103. Mauri C, Bosma A: Immune regulatory function of B cells. Annu Rev Immunol 2012, 30:221-41.
104. Li W, Bribriesco AC, Nava RG, Brescia AA, Ibricevic A, Spahn JH, Brody SL, Ritter JH, Gelman AE, Krupnick AS, Miller MJ, Kreisel D: Lung transplant acceptance is facilitated by early events in the graft and is associated with lymphoid neogenesis. Mucosal Immunol 2012, 5:544-54.
105. Lama VN, Smith L, Badri L, Flint A, Andrei A, Murray S, Wang Z, Liao H, Toews GB, Krebsbach PH, Peters-Golden M, Pinsky DJ, Martinez FJ, Thannickal VJ: Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest 2007, 117:989-96. (Pubitemid 46556755)
106. Walker N, Badri L, Wettlaufer S, Flint A, Sajjan U, Krebsbach PH, Keshamouni VG, Peters-Golden M, Lama VN: Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am J Pathol 2011, 178:2461-9.
107. Badri L, Murray S, Liu LX, Walker NM, Flint A, Wadhwa A, Chan KM, Toews GB, Pinsky DJ, Martinez FJ, Lama VN: Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2011, 183:1062-70.
108. de Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F: Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 2012, 12:574-91.
109. Yi T, Song SU: Immunomodulatory properties of mesenchymal stemcells and their therapeutic applications. Arch PharmRes 2012, 35:213-21.
110. Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN: Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a solublemediator. J Immunol 2008, 181:4389-96.
111. Banerjee ER, Laflamme MA, Papayannopoulou T, Kahn M, Murry CE, Henderson WR: Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS ONE 2012, 7:e33165.
112. Sun C, Yen C, Lin Y, Tsai T, Chang L, Kao Y, Chua S, Fu M, Ko S, Leu S, Yip H: Autologous transplantation of adipose-derivedmesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J TranslMed 2011, 9:118.
113. ChienM, BienM,KuC,Chang Y, PaoH, Yang Y,Hsiao M,Chen C, HoJH: Systemic human orbital fat-derived stem/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury. Crit Care Med 2012, 40:1245-53.
114. Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, Bonvillain RW, Lasky JA, Bunnell BA, Welsh DA, Prockop DJ, Sullivan DE: Human multipotent stromal cells attenuate lipopolysaccharideinduced acute lung injury in mice via secretion of tumor necrosis factor-a-induced protein 6. Stem Cell Res Ther 2011, 2:27.
115. Saito S, Nakayama T, Hashimoto N, Miyata Y, Egashira K, Nakao N, Nishiwaki S, Hasegawa M, Hasegawa Y, Naoe T: Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage. Am J Pathol 2011, 179:1088-94.
116. Hegab AE, Ha VL, Gilbert JL, Zhang KX, Malkoski SP, Chon AT, Darmawan DO, Bisht B, Ooi AT, Pellegrini M, Nickerson DW, Gomperts BN: Novel stem/progenitor cell population from murine tracheal submucosal gland ducts with multipotent regenerative potential. Stem Cells 2011, 29:1283-93.
117. Huh JW, Kim S, Lee JH, Lee J, van Ta Q, Kim M, Oh Y, Lee Y, Lee S: Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol 2011, 301:L255-66.
118. Firinci F, Karaman M, Baran Y, Bagriyanik A, Ayyildiz ZA, Kiray M, Kozanoglu I, Yilmaz O, Uzuner N, Karaman O: Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011, 11:1120-6.
119. Chang YS, Choi SJ, Sung DK, Kim SY, Oh W, Yang YS, Park WS: Intratracheal transplantation of human umbilical cord blood derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2011.
120. Toya SP, Li F, Bonini MG, Gomez I, Mao M, Bachmaier KW, Malik AB: Interaction of a specific population of human embryonic stem cell-derived progenitor cells with CD11b+ cells ameliorates sepsis-induced lung inflammatory injury. Am J Pathol 2011, 178:313-24.
121. Liang OD, Mitsialis SA, Chang MS, Vergadi E, Lee C, Aslam M, Fernandez-Gonzalez A, Liu X, Baveja R, Kourembanas S: Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells 2011, 29:99-107.
122. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A: Human umbilical cordmesenchymal stemcells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009, 175:303-13.
123. Song JJ, Ott HC: Bioartificial lung engineering. Am J Transplant 2012, 12:283-8.
124. Bonvillain RW, Danchuk S, Sullivan DE, Betancourt AM, Semon JA, Eagle ME, Mayeux JP, Gregory AN, Wang G, Townley IK, Borg ZD, Weiss DJ, Bunnell BA: A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization withmesenchymal stemcells. Tissue Eng Part A 2012, 18:2437-52.
125. Price AP, England KA, Matson AM, Blazar BR, Panoskaltsis-Mortari A: Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng Part A 2010, 16:2581-91.
126. Fritsche CS, Simsch O, Weinberg EJ, Orrick B, Stamm C, Kaazempur-Mofrad MR, Borenstein JT, Hetzer R, Vacanti JP: Pulmonary tissue engineering using dual-compartment polymer scaffolds with integrated vascular tree. Int J Artif Organs 2009, 32:701-10.
127. Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, Ikonomou L, Kotton D, Vacanti JP: Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010, 16:927-33.
128. Song JJ, Kim SS, Liu Z, Madsen JC, Mathisen DJ, Vacanti JP, Ott HC: Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg 2011, 92:998-1005; discussion 1005-6.
129. Cooper DKC, Ekser B, Burlak C, Ezzelarab M, HaraH, Paris L, Tector AJ, Phelps C, Azimzadeh AM, Ayares D, Robson SC, Pierson RN: Clinical lung xenotransplantation-what donor genetic modifications may be necessary? Xenotransplantation 2012, 19:144-58.
130. Burdorf L, Azimzadeh AM, Pierson RN: Xenogeneic lung transplantation models. Methods Mol Biol 2012, 885:169-89.
131. Gaca JG, Lesher A, Aksoy O, Gonzalez-Stawinski GV, Platt JL, Lawson JH, Parker W, Davis RD: Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation 2002, 73:1717-23. (Pubitemid 34655245)
132. Cantu E, Gaca JG, Palestrant D, Baig K, Lukes DJ, Gibson SE, Gonzalez-Stawinski GV, Olausson M, Parker W, Davis RD: Depletion of pulmonary intravascular macrophages prevents hyperacute pulmonary xenograft dysfunction. Transplantation 2006, 81:1157-64.
133. Li S, Waer M, Billiau AD: Xenotransplantation: role of natural immunity. Transpl Immunol 2009, 21:70-4.
134. Puga Yung GL, Li Y, Borsig L, Millard A, Karpova MB, Zhou D, Seebach JD: Complete absence of the αGal xenoantigen and isoglobotrihexosylceramide in α1,3galactosyltransferase knock-out pigs. Xenotransplantation 2012, 19:196-206.
135. Ekser B, Bianchi J, Ball S, Iwase H, Walters A, Ezzelarab M, Veroux M, Gridelli B, Wagner R, Ayares D, Cooper DKC: Comparison of hematologic, biochemical, and coagulation parameters in α 1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species. Xenotransplantation 2012, 19: 342-54.